{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:29Z","timestamp":1787240729946,"version":"build-2736575974"},"reference-count":125,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.anpedi.2010.02.009","type":"journal-article","created":{"date-parts":[[2010,4,26]],"date-time":"2010-04-26T04:46:43Z","timestamp":1272257203000},"page":"433.e1-433.e17","source":"Crossref","is-referenced-by-count":6,"title":["Calendario de vacunaciones de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones 2010"],"prefix":"10.1016","volume":"72","author":[{"given":"J.","family":"Mar\u00e8s Berm\u00fadez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"van Esso Arbolave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ar\u00edstegui Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ruiz Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gonz\u00e1lez Hachero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Merino Mo\u00edna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barrio Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"\u00c1lvarez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Cilleruelo Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortigosa del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Moreno P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2010.02.009_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.anpedi.2008.10.001","article-title":"Calendario Vacunal de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda: recomendaciones de 2009","volume":"70","author":"Bernaola","year":"2009","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2010.02.009_bib2","first-page":"51","article-title":"Recommended immunization schedules for persons aged 0 through 18 years \u2013 United States, 2010","volume":"58","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"10.1016\/j.anpedi.2010.02.009_bib3","first-page":"1008","article-title":"Licensure of a Haemophilus influenzae Type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2010.02.009_bib4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/JCM.01454-08","article-title":"Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007","volume":"47","author":"Fenoll","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.anpedi.2010.02.009_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Mu\u00f1oz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib6","unstructured":"Fenoll A, Gim\u00e9nez MJ, Vicioso MD, Aguilar L, Robledo O, Granizo JJ, et al. Trends of the ten most prevalent pneumococcal serotype among invasive isolates from children in the last 12 years in Spain. 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID). November 18-22, 2009, Buenos Aires Argentina. Book of Abstracts. Pag 285."},{"key":"10.1016\/j.anpedi.2010.02.009_bib7","unstructured":"Fenoll A, Gim\u00e9nez MJ, Vicioso MD, Aguilar L, Robledo O, Granizo JJ. Trends of prevalent pneumococcal serotypes among adult invasive isolates pre- and post-licensure of 7-PCV for children in Spain. 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID). November 18-22, 2009, Buenos Aires Argentina. Book of Abstracts. Pag 78."},{"key":"10.1016\/j.anpedi.2010.02.009_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Ep\u00ecdemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal vaccine introduction, 1997\u20132007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib9","doi-asserted-by":"crossref","first-page":"44S","DOI":"10.1111\/j.1651-2227.2000.tb00783.x","article-title":"Streptococcus pneumoniae in children in Spain: 1990\u20139","volume":"435","author":"Fenoll","year":"2000","journal-title":"Acta Pediatrn Esp"},{"key":"10.1016\/j.anpedi.2010.02.009_bib10","unstructured":"Ministerio de Sanidad y Consumo. Instituto de Salud Carlos III. Enfermedad invasora por Streptococcus pneumoniae: estudio de la incidencia de la enfermedad en menores de 5 a\u00f1os. Agosto 2004."},{"key":"10.1016\/j.anpedi.2010.02.009_bib11","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Castillo F, Hern\u00e1ndez San Pelayo T, et al. Invasive Streptococcus pneumoniae serotype distribution among hospitalized pediatric population in Madrid (May 2007-April 2008). 27th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Brussels, Belgium June 9\u201313, 2009."},{"key":"10.1016\/j.anpedi.2010.02.009_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine","volume":"12","author":"Calbo","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpedi.2010.02.009_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2009.02938.x","article-title":"Changes in serotypes causing invasive pneumococcal disease (2005\u20132007 vs 1997\u20131999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine","volume":"15","author":"Salleras","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpedi.2010.02.009_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1469-0691.2006.01646.x","article-title":"Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine","volume":"13","author":"Obando","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.anpedi.2010.02.009_bib15","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/591128","article-title":"Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population","volume":"47","author":"Romney","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Mu\u00f1oz-Almagro","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2010.02.009_bib18","unstructured":"Picazo J, Ruiz-Contreras J, Casado-Flores J, Negreira S, Castillo F, Hern\u00e1ndez Sampelayo T, et al. Serotype-specific clinical outcomes of invasive pneumococcal disease (IPD) among hospitalized pediatric population in Madrid (May 2007\u2013April 2008). 27th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Brussels, Belgium June 9\u201313, 2009."},{"key":"10.1016\/j.anpedi.2010.02.009_bib19","unstructured":"Fenoll A, Aguilar L, Vicioso MD, Gim\u00e9nez NJ, Robledo O, Granizo JJ, et al. Serotype 19A prevalence among Spanish Streptococcus pneumoniae invasive isolates (1997\u20132008) and its susceptibility to penicillin, cefotaxime and erythromycin. 6th World Congress of the World Society for Pediatric Infectious Diseases. November 18\u201322, 2009, Buenos Aires Argentina. Book of Abstracts. Pag 77."},{"key":"10.1016\/j.anpedi.2010.02.009_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1136\/bmj.332.7553.1333","article-title":"Empyema is still in UK children","volume":"332","author":"Spencer","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.anpedi.2010.02.009_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1695-4033(06)70007-8","article-title":"Derrame pleural paraneum\u00f3nico: revisi\u00f3n de 11 a\u00f1os","volume":"64","author":"Deiros","year":"2006","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2010.02.009_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":"Pediatric parapneumonic empiema, Spain","volume":"14","author":"Obando","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe fatal outcome","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib26","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/586747","article-title":"Pneumococcal necrotizing pneumonia in Utah: does serotype matter?","volume":"46","author":"Bender","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib27","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.idc.0000230541.02089.8c","article-title":"Can vaccines control resistance? The example of pneumococcal conjugate vaccine.","volume":"14","author":"Whitney","year":"2006","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.anpedi.2010.02.009_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1473-3099(08)70281-0","article-title":"Impact of conjugate pneumococcal vaccines on antibiotic resistance","volume":"8","author":"Dagan","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/423379","article-title":"Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumonia in the first two years of life","volume":"39","author":"Ghaffar","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/01.inf.0000143645.58215.f0","article-title":"Seven valent pneumococcal conjugate vaccine immunization in two Boston communities. Changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates","volume":"23","author":"Pelton","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment","volume":"365","author":"Stephens","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib33","unstructured":"Picazo JJ, Ruiz Contreras J, Casado-Flores J, Sanz F, Guti\u00e9rrez A, Bouza E, et al. Genotypic characterization and antibiotic susceptibility of Streptococcus pneumoniae serotype 19 isolates in children in Madrid, 2007\u20132008 (Heracles study). 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID). November 18\u201322, 2009, Buenos Aires Argentina. Book of Abstracts pag.51"},{"key":"10.1016\/j.anpedi.2010.02.009_bib34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1086\/597044","article-title":"Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population","volume":"199","author":"Dagan","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/528996","article-title":"Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005","volume":"197","author":"Moore","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib36","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"Siber","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib37","first-page":"64","article-title":"Pneumococcal conjugate vaccines. Recommendations for production and control of pneumococcal conjugate vaccines","volume":"927","year":"2005","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/j.anpedi.2010.02.009_bib38","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenza protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"Vesikari","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib39","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"Wysocki","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib40","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/INF.0b013e318199f901","article-title":"The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV\/Hib and poliovirus vaccines: assessment of the immunogenicity","volume":"28","author":"Bermal","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib41","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"Knuf","year":"2009","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib42","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1097\/INF.0b013e318199f62d","article-title":"Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines","volume":"28","author":"Chevallier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib43","doi-asserted-by":"crossref","unstructured":"Kieninger DM, Keuper K, Steul K, Juergens C, Ahlers N, Baker S, et al. Safety and immunologic non-inferiority of a 13-valent pneumococcal conjugate vaccine compared to 7-valent pneumococcal conjugate vaccine given as a 4 dose series with routine vaccines in healthy infants and toddlers. Presented at the 48th Annual ICAAC\/IDSA Meeting, October 25\u201328, 2008, Washington DC.","DOI":"10.1016\/j.vaccine.2010.04.008"},{"key":"10.1016\/j.anpedi.2010.02.009_bib44","unstructured":"Gadziowski J, Daniels ED, Giardina P, Patterson S, Tansey S, Emini EA, et al. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine with and without polysorbate 80 in healthy infants given at 2, 3, 4 and 12 months of age. Presented at the 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID), June 9\u201313, 2009, Brussels, Belgium."},{"key":"10.1016\/j.anpedi.2010.02.009_bib45","unstructured":"Diez-Domingo J, Gurtman A, Bernaola E, Gim\u00e9nez-S\u00e1nchez F, Martin\u00f3n-Torres F, Pineda-Solas V, et al. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy infants receiving routine vaccinations in Spain. Presented at the 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID), June 9\u201313, 2009, Brussels, Belgium."},{"key":"10.1016\/j.anpedi.2010.02.009_bib46","unstructured":"Esposito S, Tansey S, Thompson A, Ferrera G, Maida A, Bona G, et al. Safety and immunologic non-inferiority of 13-valent pneumococcal conjugate vaccine given as a 3-dose series with routine vaccines in healthy children in Italy. Presented at the 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID), June 9\u201313, 2009, Brussels, Belgium."},{"key":"10.1016\/j.anpedi.2010.02.009_bib47","unstructured":"Martinon-Torres F, Gimenez-Sanchez F, Gurtman A, Bernaola E, D\u00edez-Domingo J, Carmona A et al. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy infants receiving routine vaccinations in Spain. Presented at the 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID), June 9\u201313, 2009, Brussels, Belgium."},{"key":"10.1016\/j.anpedi.2010.02.009_bib48","unstructured":"Grimprel E, Laudat F, Baker SA, Sidhu MS, Sekaran C, Gruber WC, et al. Immunogenicity of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccination to healthy children in France. Presented at the 27th Annual Meeting of the European Society for Paediatric Infectious Disease (ESPID), June 9\u201313, 2009, Brussels, Belgium."},{"key":"10.1016\/j.anpedi.2010.02.009_bib49","series-title":"Pneumococcal vaccines. The impact of conjugate vaccines","first-page":"339","article-title":"Establishing immune correlates of protection","author":"Kohberger","year":"2008"},{"key":"10.1016\/j.anpedi.2010.02.009_bib50","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/422531","article-title":"Concentration of anti-pneumococcal antibodies as a serological correlate of protection: an application to acute otitis media","volume":"190","author":"Jokinen","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib51","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.vaccine.2009.04.021","article-title":"Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines","volume":"27","author":"Rodgers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib52","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.298.15.1772","article-title":"Emergence of multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugante vaccine as an otopathogen in children","volume":"298","author":"Pichichero","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2010.02.009_bib53","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1086\/429908","article-title":"Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine","volume":"40","author":"McEllistren","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused both Streptococcus pneumoniae and non-typeable Hemophilus influenzae: a randomized double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib55","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1086\/344191","article-title":"Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2\u20135 years of age with community-acquired pneumonia","volume":"35","author":"Esposito","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2008.05.033","article-title":"Serotypes and pathogens in paediatric pneumonia","author":"Hausdorff","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib58","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1542\/peds.2008-3422","article-title":"Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis","volume":"123","author":"Pav\u00eda","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib59","first-page":"893","article-title":"Direct and indirect effects of routine vaccination of children with 7-valent pneumococccal conjugate vaccine on incidence of invasive pneumococcal disease. United States, 1998\u20132003","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2010.02.009_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/INF.0b013e31803c56df","article-title":"Effectiveness of pneumococcal conjugate vaccines in Greater Vancouver, Canada: 2004\u20132005","volume":"26","author":"Bjornson","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib61","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.vaccine.2005.07.095","article-title":"Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults","volume":"24","author":"Metlay","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib62","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2010.02.009_bib63","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.inf.0000069761.11093.c3","article-title":"Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers","volume":"22","author":"Dagan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib64","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1016\/j.vaccine.2009.06.098","article-title":"Immunogenicity following one, two or three doses of the 7-valent pneumococcal conjugate vaccine","volume":"27","author":"Russell","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib65","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella Disease After Introduction of Varicella Vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2010.02.009_bib66","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/522145","article-title":"Varicella vaccine effectiveness in the US vaccination program","volume":"197","author":"Seward","year":"2008","journal-title":"A review. J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib67","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib68","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/522146","article-title":"Epidemiology of varicella hospitalizations in the United States, 1995-2005","volume":"197","author":"Reynolds","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib69","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpeds.2003.10.025","article-title":"Reduction in pediatric hospitalizations for varicella-related invasive group A streptococcal infections in the varicella vaccine era","volume":"144","author":"Patel","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.anpedi.2010.02.009_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib71","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in highly vaccinated school population","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib73","first-page":"389","article-title":"Outbreak of varicella among vaccinated children \u2013 Michigan. 2003","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anpedi.2010.02.009_bib74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2010.02.009_bib75","doi-asserted-by":"crossref","first-page":"6655","DOI":"10.1016\/j.vaccine.2007.07.010","article-title":"Metaanalysis of vaccine effectiveness in varicella outbreaks","volume":"25","author":"Bayer","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib76","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa064040","article-title":"Loss of vaccine-induced immunity to varicella vaccine over time","volume":"356","author":"Chaves","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib77","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1542\/peds.2004-1162","article-title":"Importance of Catch-up vaccination: experience from a varicella outbreak, Maine, 2002\u20132003","volume":"115","author":"Marin","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib78","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1542\/peds.2004-1826","article-title":"Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 2002\u20132003","volume":"115","author":"Haddad","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib79","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1086\/522150","article-title":"Varicella disease among vaccinated persons. Clinical and epidemiological characteristics, 1997\u20132005","volume":"197","author":"Chaves","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib81","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.anpedi.2010.02.009_bib82","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1086\/522130","article-title":"Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine","volume":"197","author":"Watson","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.anpedi.2010.02.009_bib83","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jinf.2002.0988","article-title":"The effect of vaccinationon in the Epidemiology of varicella zoster","author":"Edmunds","year":"2002","journal-title":"J Infect"},{"key":"10.1016\/j.anpedi.2010.02.009_bib84","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants children: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2010.02.009_bib85","series-title":"Actualizaci\u00f3n en la infecci\u00f3n por rotavirus","first-page":"41","article-title":"Vacunaci\u00f3n","author":"Moraga","year":"2009"},{"key":"10.1016\/j.anpedi.2010.02.009_bib86","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1157\/13120039","article-title":"Gastroenteritis aguda infecciosa en urgencias de un hospital urbano","volume":"68","author":"Mu\u00f1oz","year":"2008","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.anpedi.2010.02.009_bib87","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2458-8-109","article-title":"Hospitalizations associated with rotavirus gastroenteritis in Spain","volume":"8","author":"Lopez de Andr\u00e9s","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.anpedi.2010.02.009_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00431-007-0550-8","article-title":"Gastroenteritis by rotavirus in Spanish children. Analysis of the disease burden","volume":"167","author":"Luquero","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.anpedi.2010.02.009_bib89","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1542\/peds.2008-2088","article-title":"Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among european children younger than 5 years of age","volume":"123","author":"Forster","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib90","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00431-007-0466-3","article-title":"An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain","volume":"167","author":"Martin\u00f3n","year":"2008","journal-title":"Eur J Pediat"},{"key":"10.1016\/j.anpedi.2010.02.009_bib91","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib92","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/INF.0b013e3181907177","article-title":"Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials","volume":"28","author":"De Vos","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib95","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/INF.0b013e3181967bee","article-title":"Rotavirus overview","volume":"28","author":"Bernstein","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib96","unstructured":"Ome\u00f1aca F, Sarlangue J, Wysocki J, Nogueira M, Suryakiran PV, Smolenov IV, et al. Immunogenicity of a rotavirus vaccine (Rotarix\u00ae) in European pre-term infants with different gestational age. 27th Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID). Brussels, Belgium 9\u201313 June, 2009. Abstract 645, Poster 1001."},{"key":"10.1016\/j.anpedi.2010.02.009_bib97","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","article-title":"Safety and efficacy of pentavalent humans-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants","volume":"26","author":"Goveia","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib98","first-page":"1146","article-title":"Reduction in rotavirus after vaccine introduction \u2014 United States, 2000\u20132009","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2010.02.009_bib99","first-page":"1","article-title":"Recomendaciones basadas en la evidencia de la Sociedad Europea de Enfermedades Infecciosas Pedi\u00e1tricas y la Sociedad Europea de Gastroenterolog\u00eda, Hepatolog\u00eda y Nutrici\u00f3n pedi\u00e1trica para la vacunaci\u00f3n frente al rotavirus en Europa","volume":"46","author":"Vesikai","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.anpedi.2010.02.009_bib100","first-page":"533","article-title":"Rotavirus vaccines: an update","volume":"84","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.anpedi.2010.02.009_bib101","unstructured":"Pach\u00f3n I, Martinez MV, Suarez B, S\u00e1nchez-Fouquier A, Salmer\u00f3n F, Soler M, et al. Situaci\u00f3n epidemiol\u00f3gica de la gastroenteritis producida por rotavirus. Recomendaciones de la vacunaci\u00f3n frente al rotavirus. Documento enviado a la Ponencia de Programa y registro de vacunaciones, Junio 2006. Madrid: Ministerio de Sanidad y Consumo."},{"key":"10.1016\/j.anpedi.2010.02.009_bib102","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.vaccine.2009.09.097","article-title":"Safety of human papillomavirus (HPV) vaccines: a review of international experience so far","volume":"27","author":"Agorastos","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib103","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.anpedi.2010.02.009_bib104","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archpedi.1997.02170400041007","article-title":"Syncope after immunization","volume":"151","author":"Braun","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.anpedi.2010.02.009_bib105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5694\/j.1326-5377.2008.tb02018.x","article-title":"Mass Psychogenic response to human papillomavirus vaccination","volume":"189","author":"Buttery","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/j.anpedi.2010.02.009_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/INF.0b013e3181b77906","article-title":"Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (type 6, 11, 16 and 18) L1 virus-like particle vaccine","volume":"29","author":"Block","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.anpedi.2010.02.009_bib107","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/AOG.0b013e3181c2a122","article-title":"Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6\/11\/16\/18 vaccine","volume":"114","author":"Dana","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.anpedi.2010.02.009_bib108","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.vaccine.2009.02.106","article-title":"Human papillomavirus immunization of adolescent girls and anticipated reporting of immune-mediated adverse events","volume":"27","author":"Callr\u00e9us","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib109","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1542\/peds.2009-1806","article-title":"Policy statement. Recommendations for the prevention and treatment of influenza in children, 2009\u20132010","volume":"124","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.anpedi.2010.02.009_bib110","unstructured":"Recomendaciones del Comit\u00e9 Asesor de Vacunas. Vacunaci\u00f3n antigripal estacional, campa\u00f1a 2009-2010. http:\/\/www.vacunasaep.org\/gripe_2009_2010.htm"},{"key":"10.1016\/j.anpedi.2010.02.009_bib111","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009","volume":"58","author":"Fiore","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.anpedi.2010.02.009_bib112","unstructured":"Consejo Interterritorial del Sistema Nacional de Salud. Campa\u00f1a de vacunaci\u00f3n frente al nuevo virus gripal pand\u00e9mico H1N1. Recomendaciones oficiales (Versi\u00f3n 5: 21 de diciembre de 2009). http:\/\/www.aemps.es\/actividad\/documentos\/infoInteres\/docs\/campanaVacunacion_H1N1_recomenOficiales.pdf."},{"key":"10.1016\/j.anpedi.2010.02.009_bib113","unstructured":"Centers for Disease Control and Prevention. H1N1 flu. Vaccine safety. http:\/\/www.cdc.gov\/h1n1flu\/vaccination\/vaccine_safety.htm."},{"key":"10.1016\/j.anpedi.2010.02.009_bib114","unstructured":"World Health Organization. Safety of pandemic (H1N1) 2009 vaccines. http:\/\/www.who.int\/csr\/disease\/swineflu\/frequently_asked_questions\/vaccine_preparedness\/safety_approval\/en\/index.html."},{"key":"10.1016\/j.anpedi.2010.02.009_bib115","first-page":"1351","article-title":"Safety of influenza A (H1N1) 2009 monovalent vaccines \u2013 United States, October 1\u2013November 24, 2009","volume":"58","year":"2009","journal-title":"MMWR"},{"key":"10.1016\/j.anpedi.2010.02.009_bib116","article-title":"Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double blind, randomised, placebo controlled-trial","author":"Liang","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib117","article-title":"Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009\u201310 influenza season: a multicentre, randomised controlled trial","author":"Vajo","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib118","first-page":"323","article-title":"Adjuvants for pandemic influenza vaccines","volume":"333","author":"Atmar","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.anpedi.2010.02.009_bib119","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted vaccine: a randomized trial of two potential vaccines against H5N1 influenza","volume":"357","author":"Nicholson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.anpedi.2010.02.009_bib120","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0264-410X(00)00499-0","article-title":"The adjuvanted influenza vaccines with novel adjuvants: experience with the M59-adjuvanted vaccine","volume":"19","author":"Podda","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib121","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1016\/j.vaccine.2009.08.101","article-title":"MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database","volume":"27","author":"Pellegrini","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.anpedi.2010.02.009_bib122","unstructured":"Centers for Disease Control and Prevention. Catch-up Immunization Schedule for Persons Aged 4 Months Through 18 Years Who Start Late or Who Are More Than 1 Month Behind. Disponible en: http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/child\/2010\/10_catchup-schedule-pr.pdf."},{"key":"10.1016\/j.anpedi.2010.02.009_bib123","unstructured":"The Australian Immunisation Handbook 9th Edition 2008. Catch-up-updated July 2009. Disponible en: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/handbook-catchup."},{"key":"10.1016\/j.anpedi.2010.02.009_bib124","series-title":"Vacunas para enfermer\u00eda pedi\u00e1trica de atenci\u00f3n primaria","author":"Van Esso","year":"2009"},{"key":"10.1016\/j.anpedi.2010.02.009_bib125","unstructured":"Corretger JM, Baraibar R. Ni\u00f1os no vacunados: pautas aceleradas. En: Vacunas en el ni\u00f1o. De la teor\u00eda a la pr\u00e1ctica. En: Ar\u00edstegui J. editore. Junta de Andaluc\u00eda. Consejer\u00eda de Salud. Sevilla 2006; 808\u201317."}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403310001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T21:12:11Z","timestamp":1591218731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403310001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":125,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1695403310001335"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2010.02.009","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}